Skip to contentE
Endovia Health Sciences, Inc.
E
EDVAEndovia Health Sciences, Inc. Q4 2015 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$277.28K$277.28Kderived+66.7% vs Q4 2014 Net Income$54.50K$54.50KderivedN/M vs Q4 2014 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$164,355+71.9% Operating Incomederived$54,336N/M Operating Cash Flowderived$14,077−26.7% Free Cash Flowderived-$2,839— Margins · derivedGross margin59.3%+1.8 pt vs Q4 2014
Operating margin19.6%+40.4 pt vs Q4 2014
Net margin19.7%+39.4 pt vs Q4 2014
ended Dec 31, 2015 · filed Oct 3, 2016 · 277 d after period end